Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Multicompartment Models: Overview01:14

Multicompartment Models: Overview

498
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
498
Compartment Models: Two-Compartment Model01:20

Compartment Models: Two-Compartment Model

7.0K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
7.0K
Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

243
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
243
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.1K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.1K
Compartment Models: Single-Compartment Model01:14

Compartment Models: Single-Compartment Model

3.0K
The single-compartment model serves as a simplified representation of the human body. This model assumes that the body functions as a single, well-mixed open compartment. When a drug is administered intravenously, it enters the body and quickly distributes uniformly. The drug then undergoes biotransformation and elimination, ultimately leaving the body. The volume of this compartment is referred to as the apparent volume of distribution into which the drug can uniformly distribute. In this...
3.0K
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

994
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
994

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Regression analysis of a graphical proportional hazards model for informatively left-truncated current status data.

Lifetime data analysis·2025
Same author

Joint analysis of informatively interval-censored failure time and panel count data.

Statistical methods in medical research·2022
Same author

New methods for the additive hazards model with the informatively interval-censored failure time data.

Biometrical journal. Biometrische Zeitschrift·2021
Same author

Lung-Protective Ventilation Strategies for Relief from Ventilator-Associated Lung Injury in Patients Undergoing Craniotomy: A Bicenter Randomized, Parallel, and Controlled Trial.

Oxidative medicine and cellular longevity·2017
Same author

Electrochemical Oxidation of EDTA in Nuclear Wastewater Using Platinum Supported on Activated Carbon Fibers.

International journal of environmental research and public health·2017
Same author

Novel biomimetic enzyme for sensitive detection of superoxide anions.

Talanta·2017

相关实验视频

Updated: Jan 15, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K

基于Copula的Cox模型,用于依赖的当前状态数据,具有治愈分数.

Shuying Wang1, Danping Zhou1, Yunfei Yang1

  • 1School of Mathematics and Statistics, 177552 Changchun University of Technology , Changchun 130012, China.

The international journal of biostatistics
|October 9, 2025
PubMed
概括

这项研究引入了一种新的基于的生存分析方法,以解决治愈分数和依赖审查的问题. 该方法为复杂的医疗数据提供了可靠和计算可行的估计.

科学领域:

  • 生物统计学 生物统计学
  • 生存分析的分析.
  • 医学统计 医学统计

背景情况:

  • 传统的生存分析假设所有受试者都经历了事件,但由于医学进步,治愈分数是常见的.
  • 它还假定在失败和审查时间之间独立,这在实践中经常被侵犯.
  • 忽视治疗分数和依赖审查可能会导致偏见的模型估计.

研究的目的:

  • 提出一种可靠且计算可行的基于的方法,用于分析当前状态数据的治疗分数和依赖审查.
  • 在处理依赖审查数据时克服脆弱模型的局限性.

主要方法:

  • 为敏感率建立了一个物流模型,并为故障和审查时间建立了一个Cox比例危险模型.
  • 使用伯恩斯坦多项式的最大概率估计被用于参数估计.
  • 用Copula方法灵活建模变量之间的依赖关系,避免对潜在变量做出强有力的假设.

主要成果:

  • 广泛的模拟证明了在各种环境中提出的方法的一致性和非对称效率.
  • 该方法有效地处理了生存数据中的治疗分数和依赖审查.
  • 这种方法在使用淋巴毛囊细胞数据的实际数据分析中被证明是有效的.

结论:

关键词:
形模型 形模型当前状态数据当前状态数据依赖性审查 审查相称危害混合治愈模型的比例危害.

更多相关视频

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.0K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

526

相关实验视频

Last Updated: Jan 15, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.0K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

526
  • 拟议的基于的方法为治疗分数和依赖审查的生存分析提供了显著的进步.
  • 这种方法提供了比传统方法更强大的,计算上可行的替代方案.
  • 这项研究证实了该方法在现实世界医学数据分析中的实用性.